Abbott India Limited has issued a Postal Ballot Notice dated April 22, 2026, pursuant to Section 110 of the Companies Act, 2013, seeking shareholder approval for two board-level appointments. The notice was dispatched electronically on May 13, 2026, to members whose names appear in the Register of Members as on the Cut-Off Date of May 8, 2026. The resolutions will be transacted through remote e-voting, with KFin Technologies Limited (KFinTech) serving as the Registrar and Transfer Agent and e-voting service provider.

Proposed Board Appointments

The Postal Ballot Notice covers two resolutions for member consideration. The appointments were initially made by the Board of Directors on April 22, 2026, upon recommendation of the Nomination and Remuneration Committee, and now require formal shareholder ratification.

Profile of Mr. James Wenner

Mr. James Wenner (DIN: 11650998), aged 58 years, holds a degree in Accounting from Michigan State University and is a Certified Public Accountant. He currently serves as Vice President, Treasurer for Abbott Laboratories, USA, a role he was appointed to in November 2025. Prior to this, he served as Vice President, Internal Audit for Abbott Laboratories, USA. Mr. Wenner joined Abbott in 1994 as a Senior Auditor and has since held numerous finance leadership roles within the Nutrition and Diagnostics businesses. He is active in Abbott's Finance Development Committee and serves as Chairman of the Board for ALEC, the Abbott and AbbVie sponsored employee credit union. Before joining Abbott, he was a Certified Public Accountant with Deloitte. His appointment as a Non-Executive Director is subject to approval by an Ordinary Resolution. No remuneration is sought to be paid to Mr. Wenner in this capacity.

Profile of Mr. Neeraj Jain

Mr. Neeraj Jain (DIN: 00348591), aged 64 years, is a rank holder Chartered Accountant and Company Secretary with over 30 years of management experience in finance, supply chain and business across diversified industries. His appointment fills the vacancy created upon the completion of the second term of Ms. Anisha Motwani (DIN: 06943493) as Independent Director on April 24, 2026. Key areas of his expertise include:

• Strategic business partnering and process excellence
• Controllership, M&A, and business reorganization
• Talent development and compliance optimization

Mr. Jain began his career in management consulting at A F Ferguson, subsequently spending seventeen years with Hindustan Unilever (HUL), with his last role being General Manager, Commercial (Exports). He later joined Johnson & Johnson (J&J), where he served for thirteen years in senior leadership roles including Vice President Finance/Chief Financial Officer, and was a member of the India Management Board. Post his retirement from J&J in 2020, he co-founded Vinnies, an angel investment platform comprising approximately 150 CXOs, and serves as its founding director. He was recognized among the 100 most influential CFOs in India by CIMA in 2016 and by 9.9 Media in 2015. His appointment as Independent Director for 3 (three) consecutive years from April 25, 2026 requires approval by a Special Resolution.

Mr. Neeraj Jain — Board and Committee Positions (Other Entities)

E-Voting Schedule and Process

The remote e-voting facility is being provided through KFinTech's platform. Members whose names appear in the Register of Members as on the Cut-Off Date of May 8, 2026, are entitled to participate. The voting schedule is as follows:

The Scrutinizer for the Postal Ballot process is Mr. Taizoon Khumri (CP No. 88 and Membership No. FCS 993), failing him Mr. Husain Wagh (CP No. 12153 and Membership No. FCS 11268), failing him Ms. Fatema Fatehi (CP No. 18684 and Membership No. ACS 51448), partners of M/s. Khumri Wagh Fatehi & Associates LLP, Practicing Company Secretaries. If approved, the resolutions shall be deemed to have been passed on June 16, 2026, the last date of e-voting. Results will be published on the Company's website at www.abbott.co.in and on KFinTech's e-voting portal at https://evoting.kfintech.com , and communicated simultaneously to BSE Limited.

Abbott India Limited has announced significant changes to its board composition and senior management structure following a comprehensive board meeting held on April 22, 2026. The pharmaceutical company disclosed multiple director transitions and key appointments that will reshape its leadership team.

Board Director Transitions

The company announced several director changes taking effect over the coming days. Ms. Anisha Motwani will complete her second term as Independent Director on April 24, 2026, ceasing her directorship at the close of business hours on that date. Simultaneously, Ms. Alison Davies tendered her resignation as Director effective April 22, 2026, citing other professional commitments as the reason for her departure.

New Director Appointments

The board has approved two significant appointments to fill the vacant positions. Mr. Neeraj Jain has been appointed as Additional Director designated as Independent Director for a period of 3 consecutive years with effect from April 25, 2026. Mr. James Wenner has been appointed as Additional Non-Executive Director effective April 23, 2026.

Mr. Neeraj Jain - Independent Director Profile

Mr. Neeraj Jain brings over 30 years of management experience across finance, supply chain, and business operations in diversified industries. He is a rank holder Chartered Accountant and Company Secretary with extensive expertise at Johnson & Johnson and Hindustan Unilever. His key areas of expertise include strategic business partnering, process excellence, controllership, M&A, business reorganization, and talent development.

Mr. Jain began his career in management consulting at A F Fergusons before spending seventeen years with HUL in positions of increasing responsibility. He later joined J&J for thirteen years in senior leadership roles, including Vice President Finance/Chief Financial Officer. Post retirement from J&J in 2020, he co-founded Vinnners, an angel investment platform comprising approximately 150 CXOs.

Mr. James Wenner - Non-Executive Director Profile

Mr. James Wenner currently serves as Vice President, Treasurer for Abbott Laboratories, USA, appointed to this role in November 2025. He previously served as Vice President, Internal Audit for Abbott Laboratories and joined Abbott in 1994 as a Senior Auditor. Throughout his tenure, he has held numerous finance leadership roles within the Nutrition and Diagnostics businesses.

Prior to joining Abbott, Mr. Wenner was a Certified Public Accountant with Deloitte and holds a degree in Accounting from Michigan State University. He is active in Abbott's Finance Development Committee and serves as Chairman of the Board for ALEC, the Abbott and AbbVie sponsored employee credit union.

Senior Management Changes at Goa Plant

The company announced significant changes to its Goa manufacturing facility leadership. Mr. Tushar Singh, Plant Director - Goa, has been assigned to another Abbott affiliate effective June 1, 2026. He will continue serving in his current role until May 31, 2026.

Mr. Amol Metkar - New Plant Director Profile

Mr. Amol Metkar has been appointed as Plant Director - Goa effective June 1, 2026. He joined Abbott in 2017 as Manager Production at EPD Goa site and has taken on roles of increasing responsibility. He previously served as Head of Production – Hormones at Baddi and Senior Manager – Production at Goa manufacturing site.

Currently serving as Associate Director – Production at Abbott's Established Pharmaceuticals Division in Baddi, Mr. Metkar leads the Oral Dosage Forms manufacturing operations across tablets, capsules, and liquids. Prior to Abbott, he worked at Lupin, Sanofi, Cipla, and Ranbaxy. He holds a Bachelor's Degree in Pharmacy Technology from Poona College of Pharmacy, Pune, along with various certifications including Lean Six Sigma Black Belt.

Postal Ballot Approval Process

The board has approved a Postal Ballot Notice to seek shareholder approval for the new director appointments. The notice will cover the appointment of Mr. Neeraj Jain as Independent Director for 3 consecutive years and Mr. James Wenner as Non-Executive Director. The Postal Ballot Notice will be sent to shareholders in due course and filed with the Stock Exchange.

The board meeting commenced at 11.45 am and concluded at 12.10 pm on April 22, 2026, with all decisions made in accordance with SEBI regulations and listing requirements.